Insider · CIK 0001397763
George E Kilguss III
cfoofficer
Files at VRSN (VERISIGN INC/CA). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 15, 2025 | VRSN VERISIGN INC/CA | FTax withholding Common Stock | -170 | $229.24 | $39k | 125,247 | Feb 19, 2025 |
| Feb 15, 2025 | VRSN VERISIGN INC/CA | FTax withholding Common Stock | -184 | $229.24 | $42k | 125,063 | Feb 19, 2025 |
| Feb 15, 2025 | VRSN VERISIGN INC/CA | FTax withholding Common Stock | -211 | $229.24 | $48k | 124,852 | Feb 19, 2025 |
| Feb 15, 2025 | VRSN VERISIGN INC/CA | FTax withholding Common Stock | -1,008 | $229.24 | $231k | 123,844 | Feb 19, 2025 |
| Feb 13, 2025 | VRSN VERISIGN INC/CA | AGrant or award Common Stock | +4,850 | $0.00 | $0 | 126,975 | Feb 18, 2025 |
| Feb 13, 2025 | VRSN VERISIGN INC/CA | FTax withholding Common Stock | -1,558 | $229.34 | $357k | 125,417 | Feb 18, 2025 |
| Feb 10, 2025 | VRSN VERISIGN INC/CA | AGrant or award Common Stock | +7,878 | $0.00 | $0 | 122,125 | Feb 12, 2025 |
| Nov 15, 2024 | VRSN VERISIGN INC/CA | FTax withholding Common Stock | -170 | $180.88 | $31k | 114,521 | Nov 18, 2024 |
| Nov 15, 2024 | VRSN VERISIGN INC/CA | FTax withholding Common Stock | -184 | $180.88 | $33k | 114,337 | Nov 18, 2024 |
| Nov 15, 2024 | VRSN VERISIGN INC/CA | FTax withholding Common Stock | -211 | $180.88 | $38k | 114,126 | Nov 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.